Biotech Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Biotech Clinical Trials in Mexico

Biotech Clinical Trials in Mexico – Cohortias the CRO of LATAM

Biotechnology has revolutionized the healthcare industry, bringing forth innovative therapies and treatments. Clinical trials play a crucial role in evaluating the safety and efficacy of these biotech products. Mexico, a rapidly growing hub for biomedical research, has been actively participating in biotech clinical trials.

This article explores the advancements, challenges, and promising prospects associated with biotech clinical trials in Mexico.

Advancements in Biotech Clinical Trials in Mexico


Mexico has made significant strides in biotech clinical trials, attracting both domestic and international researchers. The country offers a diverse patient population, advanced research facilities, and a favorable regulatory environment.


Its robust scientific community and increasing investment in healthcare infrastructure have contributed to the expansion of clinical trials in the biotech sector.


Regulatory Framework


Mexico’s regulatory agency, the Federal Commission for Protection against Sanitary Risks (COFEPRIS), oversees the approval and regulation of clinical trials. COFEPRIS has implemented efficient procedures to facilitate the timely initiation and conduct of biotech clinical trials. The agency has harmonized its regulations with international standards, ensuring patient safety and data integrity.


Collaboration with International Partners


Mexico has actively engaged in collaborations with international partners, including pharmaceutical companies, academic institutions, and contract research organizations (CROs). These partnerships have facilitated knowledge exchange, technology transfer, and access to global expertise. Such collaborations have led to the successful completion of numerous biotech clinical trials in Mexico.


Therapeutic Areas and Innovation


Biotech clinical trials in Mexico span a wide range of therapeutic areas, including oncology, infectious diseases, neurology, and rare genetic disorders. The country’s research institutions and hospitals have contributed to breakthrough discoveries and the development of novel biotech therapies. Mexico’s rich biodiversity also offers unique opportunities for the exploration of natural products with therapeutic potential.


Biotech Clinical Trials in Mexico

Biotech Clinical Trials in Mexico

Biotech Clinical Trials in Mexico

Patient Recruitment and Diversity


Mexico’s diverse population provides an advantage for patient recruitment in clinical trials. This diversity allows for a better understanding of the impact of biotech products on different ethnic groups and genetic backgrounds. The inclusion of underrepresented populations in clinical trials helps ensure equitable access to innovative treatments and therapies.


Challenges and Mitigation


Despite the progress made, challenges persist in biotech clinical trials in Mexico. Limited financial resources, lack of public awareness, and infrastructural gaps are some of the hurdles faced by researchers.


However, concerted efforts by the government, academia, and industry stakeholders are being made to address these challenges. Increased funding, educational campaigns, and infrastructure development initiatives are being implemented to overcome these obstacles.


Ethical Considerations and Patient Protection


Ethics committees and Institutional Review Boards (IRBs) in Mexico play a vital role in ensuring patient protection and ethical conduct of clinical trials. These bodies evaluate study protocols, informed consent procedures, and monitor trial progress. Strict adherence to ethical guidelines and international standards ensures the well-being and rights of trial participants.


Future Prospects


The future of biotech clinical trials in Mexico appears promising. The government’s commitment to strengthening the healthcare sector, coupled with increased public-private partnerships, is expected to fuel further growth. The incorporation of innovative technologies, such as precision medicine and gene therapy, holds immense potential for the advancement of biotech research in Mexico.


Mexico has emerged as an active participant in biotech clinical trials, showcasing advancements, overcoming challenges, and paving the way for promising prospects. The country’s favorable regulatory environment, diverse patient population, and collaborative efforts with international partners have accelerated the growth of biotech research.

With continued investment and support, Mexico is poised to make significant contributions to the development of safe and effective biotech therapies, benefiting both its population and the global healthcare community.


Biotech Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Biotech Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Biotech Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Biotech Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Biotech Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Biotech Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Biotech Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Biotech Clinical Trials in Mexico

The Cohortias Team

Biotech Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Biotech Clinical Trials in Mexico

Network & Partnerships